The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after
…, HJ Asbun, MG Besselink, K Conlon, M Del Chiaro… - Surgery, 2017 - Elsevier
Background In 2005, the International Study Group of Pancreatic Fistula developed a
definition and grading of postoperative pancreatic fistula that has been accepted universally. …
definition and grading of postoperative pancreatic fistula that has been accepted universally. …
Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines
NCM Van Huijgevoort, M Del Chiaro… - Nature reviews …, 2019 - nature.com
Pancreatic cystic neoplasms (PCN) are a heterogeneous group of pancreatic cysts that
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …
The Miami international evidence-based guidelines on minimally invasive pancreas resection
…, U Boggi, MP Callery, M Del Chiaro… - Annals of …, 2020 - journals.lww.com
Objective: The aim of this study was to develop and externally validate the first evidence-based
guidelines on minimally invasive pancreas resection (MIPR) before and during the …
guidelines on minimally invasive pancreas resection (MIPR) before and during the …
European experts consensus statement on cystic tumours of the pancreas
M Del Chiaro, C Verbeke, R Salvia, G Klöppel… - Digestive and Liver …, 2013 - Elsevier
Cystic lesions of the pancreas are increasingly recognized. While some lesions show benign
behaviour (serous cystic neoplasm), others have an unequivocal malignant potential (…
behaviour (serous cystic neoplasm), others have an unequivocal malignant potential (…
[HTML][HTML] Neoadjuvant treatment in pancreatic cancer
…, MH Al-Musawi, RD Schulick, M Del Chiaro - Frontiers in …, 2020 - frontiersin.org
Thanks to the development of modern chemotherapeutic regimens, survival after surgery for
pancreatic ductal adenocarcinoma (PDAC) has improved and pancreatologists worldwide …
pancreatic ductal adenocarcinoma (PDAC) has improved and pancreatologists worldwide …
[HTML][HTML] Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer
M Del Chiaro, E Rangelova, A Halimi, Z Ateeb… - Hpb, 2019 - Elsevier
Background Few studies have investigated the outcome of pancreatectomy associated with
artery resection (PAR). Methods Retrospective analysis of a cohort of operated borderline or …
artery resection (PAR). Methods Retrospective analysis of a cohort of operated borderline or …
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
…, IQ Molenaar, JW Wilmink, M Del Chiaro… - Nature Reviews …, 2024 - nature.com
Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for
patients with localized pancreatic cancer. Upfront surgery is considered suboptimal in cases …
patients with localized pancreatic cancer. Upfront surgery is considered suboptimal in cases …
Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology
…, EG Chiorean, V Chung, B Czito, M Del Chiaro… - Journal of the National …, 2021 - jnccn.org
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women
in the United States. A major challenge in treatment remains patients’ advanced disease …
in the United States. A major challenge in treatment remains patients’ advanced disease …
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) …
…, KA Overbeek, R Brand, S Syngal, M Del Chiaro… - Gut, 2020 - gut.bmj.com
Background and aim The International Cancer of the Pancreas Screening Consortium met
in 2018 to update its consensus recommendations for the management of individuals with …
in 2018 to update its consensus recommendations for the management of individuals with …
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity
E Giovannetti, N Funel, GJ Peters, M Del Chiaro… - Cancer research, 2010 - AACR
MicroRNA-21 (miR-21) was reported to be overexpressed and contributes to invasion and
gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC). The aim of this study …
gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC). The aim of this study …